Univest
Univest
  • Markets
  • Twenty Percent Quarterly Profit Growth Stocks to Buy in November 2026: 5 Names on the Watchlist

    • November 6, 2026
    • Posted by: Kunal Singla
    • Category: Best Stocks
    No Comments
    Twenty Percent Quarterly Profit Growth Stocks to Buy in November 2026: 5 Names on the Watchlist

    Five twenty percent quarterly profit growth stocks on the November 2026 watchlist with FY26 growth, valuation, ROE, shareholding and risks for Affle 3i, ICICI Bank, LIC, Sun Pharma and Time Techno.

    read more
  • 3 Automotive Lighting Systems Maker, Global Pharmaceutical Company and Largest Pharmaceutical Company Stocks With a Strong Future Roadmap: Lumax Industries, Lupin and Sun Pharma

    • November 6, 2026
    • Posted by: Chaitanya Auti
    • Category: Best Stocks
    No Comments
    3 Automotive Lighting Systems Maker, Global Pharmaceutical Company and Largest Pharmaceutical Company Stocks With a Strong Future Roadmap: Lumax Industries, Lupin and Sun Pharma

    Auto Lighting, Global Pharma, Drug Major Stocks with a strong future roadmap: Lumax Industries, Lupin and Sun Pharma. Compare price, valuation, return on equity and revenue growth as of 5 November 2026.

    read more
  • Pharma and Healthcare Stocks: A Defensive Theme for Samvat 2083 After Nifty Pharma’s 21% Gain in Samvat 2082?

    • November 5, 2026
    • Posted by: Chaitanya Auti
    • Category: Market
    No Comments
    Pharma and Healthcare Stocks: A Defensive Theme for Samvat 2083 After Nifty Pharma's 21% Gain in Samvat 2082?

    Nifty Pharma rose 21.4% in Samvat 2082. Are pharma and healthcare stocks still a defensive theme for Samvat 2083? Growth drivers, US tariffs and risks.

    read more
  • Under Rs 1900 Stocks to Buy in November 2026: 5 Names on the Watchlist

    • November 5, 2026
    • Posted by: Kunal Singla
    • Category: Best Stocks
    No Comments
    Under Rs 1900 Stocks to Buy in November 2026: 5 Names on the Watchlist

    Five under Rs 1900 stocks on the November 2026 watchlist with FY26 growth, valuation, ROE, shareholding and risks for Kalpataru Projects, Astral, Gravita India, Cholamandalam and Sun Pharma.

    read more
  • 3 Private Hospital Network, Single Use Medical Devices Maker and Largest Pharma Company Stocks With a Strong Future Roadmap: Apollo Hospitals Enterprise, Poly Medicure and Sun Pharma

    • November 4, 2026
    • Posted by: Harsh Piplani
    • Category: Best Stocks
    No Comments
    3 Private Hospital Network, Single Use Medical Devices Maker and Largest Pharma Company Stocks With a Strong Future Roadmap: Apollo Hospitals Enterprise, Poly Medicure and Sun Pharma

    Hospital Chain, Medical Device and Pharma Stocks with a strong future roadmap: Apollo Hospitals Enterprise, Poly Medicure and Sun Pharma. Compare price, valuation, return on equity and revenue growth as of 3 November 2026.

    read more
  • Under Rs 2500 Stocks to Buy in November 2026: 5 Names on the Watchlist

    • November 4, 2026
    • Posted by: Ankit Jaiswal
    • Category: Best Stocks
    No Comments
    Under Rs 2500 Stocks to Buy in November 2026: 5 Names on the Watchlist

    Five under Rs 2500 stocks on the November 2026 watchlist with FY26 growth, valuation, ROE, shareholding and risks for Bajaj Finserv, Sun Pharma, Adani Ports, Ipca Labs and Power Mech.

    read more
  • Mumbai Stocks to Buy in November 2026: 5 Names on the Watchlist

    • November 4, 2026
    • Posted by: Chaitanya Auti
    • Category: Best Stocks
    No Comments
    Mumbai Stocks to Buy in November 2026: 5 Names on the Watchlist

    Five Mumbai stocks on the November 2026 watchlist with FY26 growth, valuation, ROE, shareholding and risks for L&T, Sun Pharma, Phoenix, Ajanta Pharma and Ipca Labs.

    read more
  • Sun Pharma Q2 FY27 Results: Net Profit Falls 36% to Rs 1,989 Crore on Rs 1,269 Crore One-Time Charges, While Adjusted Profit Rises 1.4% and Revenue Climbs 12%

    • November 2, 2026
    • Posted by: Kunal Singla
    • Category: Results
    No Comments
    Sun Pharma Q2 FY27 Results: Net Profit Falls 36% to Rs 1,989 Crore on Rs 1,269 Crore One-Time Charges, While Adjusted Profit Rises 1.4% and Revenue Climbs 12%

    Sun Pharma Q2 results: profit fell 36% to Rs 1,989 crore on one-time charges, but adjusted profit rose 1.4% and revenue 12%. India strong, US weak. Share price and what to watch.

    read more
  • 3 Multi Speciality Hospital Chain, Pathology and Diagnostics Company and Largest Pharma Company Stocks With a Strong Future Roadmap: Max Healthcare Institute, Metropolis Healthcare and Sun Pharma

    • October 30, 2026
    • Posted by: Neeraj Pandey
    • Category: Best Stocks
    No Comments
    3 Multi Speciality Hospital Chain, Pathology and Diagnostics Company and Largest Pharma Company Stocks With a Strong Future Roadmap: Max Healthcare Institute, Metropolis Healthcare and Sun Pharma

    Hospital, Pathology and Pharma Leader Stocks with a strong future roadmap: Max Healthcare Institute, Metropolis Healthcare and Sun Pharma. Compare price, valuation, return on equity and revenue growth as of 28 October 2026.

    read more
  • 3 India’s Largest Pharma Company, Complex Generics and Oncology Specialist and Branded Generics Maker Stocks With a Strong Future Roadmap: Sun Pharma, Natco Pharma and Lincoln Pharmaceuticals

    • October 30, 2026
    • Posted by: Harsh Piplani
    • Category: Best Stocks
    No Comments
    3 India's Largest Pharma Company, Complex Generics and Oncology Specialist and Branded Generics Maker Stocks With a Strong Future Roadmap: Sun Pharma, Natco Pharma and Lincoln Pharmaceuticals

    Branded Generic and Oncology Drug Stocks with a strong future roadmap: Sun Pharma, Natco Pharma and Lincoln Pharmaceuticals. Compare price, valuation, return on equity and revenue growth as of 28 October 2026.

    read more
  • 1
  • 2
  • 3